Market Price

37.80 

-1.60 -4.1%

as of Jun 04 '20

52 Week Range:

28.80 48.60


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 1.58
2.25
2.79
3.14
3.37
3.94
4.21
4.11
3.93
4.56
4.90
growth rate 42.4% 24.0% 12.5% 7.3% 16.9% 6.9% -2.4% -4.4% 16.0% 7.5%
Earnings BIT 155.90
182.60
207.80
235.60
271.30
304.40
growth rate 17.1% 13.8% 13.4% 15.2% 12.2%
Avg.PE 24.07
23.79
48.14
29.21
24.60
growth rate -1.2% 102.4% -39.3% -15.8%
ROA 7.10
7.01
5.66
4.35
4.17
2.94
5.65
8.68
4.18
8.82
8.05
growth rate -1.3% -19.3% -23.1% -4.1% -29.5% 92.2% 53.6% -51.8% 111.0% -8.7%
ROE 22.27
20.26
16.11
11.67
10.32
7.03
13.62
21.75
11.13
22.16
21.87
growth rate -9.0% -20.5% -27.6% -11.6% -31.9% 93.7% 59.7% -48.8% 99.1% -1.3%
ROIC 15.64
14.26
11.01
8.76
7.86
5.58
10.53
15.77
7.87
15.70
13.72
growth rate -8.8% -22.8% -20.4% -10.3% -29.0% 88.7% 49.8% -50.1% 99.5% -12.6%
Cur. Ratio 1.61
1.26
1.58
1.92
2.21
2.34
2.22
2.43
2.59
2.18
2.78
growth rate -21.7% 25.4% 21.5% 15.1% 5.9% -5.1% 9.5% 6.6% -15.8% 27.5%
Quick Ratio 0.72
0.56
0.70
0.88
1.15
1.35
1.27
1.42
1.45
1.13
1.62
growth rate -22.2% 25.0% 25.7% 30.7% 17.4% -5.9% 11.8% 2.1% -22.1% 43.4%
Leverage 2.81
2.95
2.75
2.63
2.35
2.43
2.38
2.63
2.69
2.37
3.06
growth rate 5.0% -6.8% -4.4% -10.7% 3.4% -2.1% 10.5% 2.3% -11.9% 29.1%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 293.20
234.70
243.90
319.30
383.10
406.10
growth rate -20.0% 3.9% 30.9% 20.0% 6.0%
Acct.Payable 76.00
72.10
86.10
90.80
104.50
118.40
growth rate -5.1% 19.4% 5.5% 15.1% 13.3%
Cur.Assets 1,366.30
1,231.50
1,275.90
1,358.80
1,304.30
1,796.30
growth rate -9.9% 3.6% 6.5% -4.0% 37.7%
Total Assets 1,864.80
1,730.00
1,808.40
1,948.50
2,128.60
2,771.50
growth rate -7.2% 4.5% 7.8% 9.2% 30.2%
Cash 319.50
267.10
342.40
325.00
322.40
678.30
growth rate -16.4% 28.2% -5.1% -0.8% 110.4%
Inventory 477.40
422.00
440.40
486.20
509.60
577.20
growth rate -11.6% 4.4% 10.4% 4.8% 13.3%
Cur.Liabilities 582.70
554.50
524.70
524.50
599.30
645.60
growth rate -4.8% -5.4% 0.0% 14.3% 7.7%
Liabilities 1,093.10
997.10
1,115.30
1,215.00
1,200.90
1,833.30
growth rate -8.8% 11.9% 8.9% -1.2% 52.7%
LT Debt 354.20
265.20
391.60
414.30
315.50
828.60
growth rate -25.1% 47.7% 5.8% -23.9% 162.6%
Equity 765.90
726.10
686.40
725.40
896.60
906.80
growth rate -5.2% -5.5% 5.7% 23.6% 1.1%
Common Shares 165.00
165.00
167.00
167.00
169.00
170.00
169.00
162.00
159.00
157.00
156.00
growth rate 0.0% 1.2% 0.0% 1.2% 0.6% -0.6% -4.1% -1.9% -1.3% -0.6%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 33.80
34.20
37.10
43.70
49.20
73.00
growth rate 1.2% 8.5% 17.8% 12.6% 48.4%
Cash Dividends 25.80
25.80
25.80
25.40
25.10
25.00
growth rate 0.0% 0.0% -1.6% -1.2% -0.4%
Cash From OA 114.30
229.20
130.80
154.40
239.70
213.40
growth rate 100.5% -42.9% 18.0% 55.3% -11.0%
FCF per Share 0.59
0.54
0.18
0.33
0.17
0.68
0.64
0.88
0.52
0.95
0.82
growth rate -8.5% -66.7% 83.3% -48.5% 300.0% -5.9% 37.5% -40.9% 82.7% -13.7%
Sale Purchase of Stock 8.20
10.80
11.50
20.00
growth rate 31.7% 6.5% 73.9%
FCF 134.00
124.00
33.00
60.00
95.00
81.00
195.00
94.00
111.00
191.00
140.00
growth rate -7.5% -73.4% 81.8% 58.3% -14.7% 140.7% -51.8% 18.1% 72.1% -26.7%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 1,808.90
1,623.80
1,611.30
1,765.90
1,895.60
2,072.60
growth rate -10.2% -0.8% 9.6% 7.3% 9.3%
Op.Income 155.90
182.60
207.80
235.60
271.30
304.40
growth rate 17.1% 13.8% 13.4% 15.2% 12.2%
IBT 101.30
128.00
177.60
197.80
244.70
280.40
growth rate 26.4% 38.8% 11.4% 23.7% 14.6%
Net Income 56.70
101.60
153.60
78.60
179.70
197.20
growth rate 79.2% 51.2% -48.8% 128.6% 9.7%
EPS 0.49
0.58
0.55
0.46
0.48
0.33
0.60
0.95
0.49
1.14
1.26
growth rate 18.4% -5.2% -16.4% 4.4% -31.3% 81.8% 58.3% -48.4% 132.7% 10.5%
Gross Profit 788.30
729.80
756.30
821.60
902.60
1,000.60
growth rate -7.4% 3.6% 8.6% 9.9% 10.9%
R&D 174.20
145.70
147.90
161.60
173.40
187.70
growth rate -16.4% 1.5% 9.3% 7.3% 8.3%

Quarterly Statements

Item Name Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Earnings BIT 49.70
55.50
81.30
118.50
17.20
growth rate 11.7% 46.5% 45.8% -85.5%
Balance Sheet Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Acct.Receivable 391.90
385.20
396.90
406.10
325.50
growth rate -1.7% 3.0% 2.3% -19.9%
Acct.Payable 126.50
123.70
116.60
118.40
127.00
growth rate -2.2% -5.7% 1.5% 7.3%
Cur.Assets 1,343.70
1,406.40
1,434.00
1,796.30
1,990.00
growth rate 4.7% 2.0% 25.3% 10.8%
Total Assets 2,242.50
2,349.70
2,352.10
2,771.50
2,961.90
growth rate 4.8% 0.1% 17.8% 6.9%
Cash 298.80
282.50
296.30
678.30
795.50
growth rate -5.5% 4.9% 128.9% 17.3%
Inventory 541.80
594.60
586.70
577.20
625.50
growth rate 9.8% -1.3% -1.6% 8.4%
Cur.Liabilities 632.70
641.00
643.00
645.60
765.80
growth rate 1.3% 0.3% 0.4% 18.6%
Liabilities 1,298.90
1,457.60
1,476.50
1,833.30
2,037.30
growth rate 12.2% 1.3% 24.2% 11.1%
LT Debt 331.70
493.20
517.50
828.60
914.80
growth rate 48.7% 4.9% 60.1% 10.4%
Equity 913.20
860.80
845.20
906.80
924.60
growth rate -5.7% -1.8% 7.3% 2.0%
Common Shares 1.70
1.70
1.70
1.70
924.60
growth rate 0.0% 0.0% 0.0% 54,288.2%
Cash Flow Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Capital Expenditures 10.60
18.00
16.20
28.20
30.50
growth rate 69.8% -10.0% 74.1% 8.2%
Cash Dividends 6.30
6.30
6.20
6.20
6.20
growth rate 0.0% -1.6% 0.0% 0.0%
Cash From OA 14.20
10.60
52.40
136.20
35.00
growth rate -25.4% 394.3% 159.9% -74.3%
Sale Purchase of Stock
growth rate
FCF 3.60
-7.40
36.20
108.00
4.50
growth rate -100.0% 100.0% 198.3% -95.8%
Income Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Sales 461.40
490.20
521.10
599.90
424.00
growth rate 6.2% 6.3% 15.1% -29.3%
Op.Income 49.70
55.50
81.30
118.50
17.20
growth rate 11.7% 46.5% 45.8% -85.5%
IBT 38.40
47.60
83.20
111.20
13.50
growth rate 24.0% 74.8% 33.7% -87.9%
Net Income 30.80
36.50
61.30
68.60
10.50
growth rate 18.5% 68.0% 11.9% -84.7%
Gross Profit 217.60
231.00
254.50
297.50
193.10
growth rate 6.2% 10.2% 16.9% -35.1%
R&D 46.40
48.50
46.10
46.70
48.50
growth rate 4.5% -5.0% 1.3% 3.9%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (62.52)

YOY Growth Grade:

E (33.09)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 34.28 33.39
EPS / Growth 1.13

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 6.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.4% 6.4% 6.4%
Future PE 0.01 6.38 6.38
Future EPS 2.10 2.10 2.10
Value Price
MOS %
0.01
-100.0%
3.31
-91.2%
3.31
-91.2%
MOS Price 0.00 1.65 1.65
IRT 17.78 17.78 17.78

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.